Drapalin 10/11 Batha Balanced is a balanced hybrid strain with a harmounious indica-sativa ratio. It is a cross from our internal genetic program between Bafokeng Choice and an early phenotype of Grape Cluster. The target with this strain was to emulate a balanced version of the iconic Grandaddy Purple genetic.
This novel cannabis strain is characterized by a firm flower with a distinct aroma. The terpene profile features a high content of β-caryophyllene, β-myrcene, α-humulene and d-limonene.
Effect profile
- Reduction of side effects
- Enhancement of therapeutic benefits
Recommendation
- Spasticity
- Chronic pain
- Sleep disorders
Terpenes encompass a diverse group of volatile and aromatic organic compounds that pervade the intricate botanical structure of the plant’s flowers and leaves. These compounds exhibit structural complexity, characterized by the presence of isoprene units and a plethora of functional groups.
Terpenes play a vital role in the overall chemical composition of cannabis, contributing to its distinct scent, flavour, and potential therapeutic effects. Through their synergistic interactions with other constituents, terpenes have been implicated in modulating the physiological and psychoactive properties of cannabinoids, thereby influencing the intricate pharmacological profile of cannabis-based products.
Cultivar
THC/CBD (m/m)
Treatment
Genetics
Shelf life
Batha Balanced (Hybrid, Indica / Sativa)
THC 8.5-11.5% CBD 9.5-12.5%
Not irradiated
Bafokeng Choice x Grape Cluster 176
12 months
Cultivar: Batha Balanced (Hybrid, Indica / Sativa)
THC- / CBD-Content (m/m): THC 8.5-11.5% CBD 9.5-12.5%
Treatment: Not irradiated
Genetics: Bafokeng Choice x Grape Cluster 176
Shelf Life: 12 months
Medication
Intake
Areas of
application
Since the prescription of medical cannabis flowers to patients is a formulation prescription, the decision on the therapeutic area of application rests with the prescribing physician. Based on the symptoms, medical cannabis is currently most frequently used in Germany for the following diseases:
Pain
Anorexia / Cachexia
Depression
Lack of appetite
Insomnia
Spacticity
Inflammatory bowel diseases
Epilepsy
ADHD
Multiple Sclerosis
Tic disorders / Tourette Syndrom
Nausea / Vomiting
MG Health is about quality and safety
MG Health is a well-established medical cannabis manufacturer and our partner in Lesotho. In this landlocked South African country, the medicinal plant is cultivated at an altitude of 2000m in a mountainous environment far away from any industry. These optimal natural conditions, the qualified personnel, and the state-of-the-art facilities guarantee pharmaceutical production at the highest level. The local population’s quality of life has also improved remarkably since the company’s inception five years ago.
MG Health is about quality and safety
MG Health is a well-established medical cannabis manufacturer and our partner in Lesotho. In this landlocked South African country, the medicinal plant is cultivated at an altitude of 2000m in a mountainous environment far away from any industry. These optimal natural conditions, the qualified personnel, and the state-of-the-art facilities guarantee pharmaceutical production at the highest level. The local population’s quality of life has also improved remarkably since the company’s inception five years ago.
Andre Bothma
"When we started this company, we didn’t just want to make a profit, we wanted to change lives, and what better way to do that than through education and jobs?"
THESE PRODUCTS ARE DISTRIBUTED IN GERMANY BY DRAPALIN
Drapalin Pharmaceuticals GmbH from Munich has been acting as one of the first German importers and wholesalers of medical cannabis since 2018. Their reliable supply of quality products and the active exchange of knowledge with physicians, pharmacists and patient associations establishes their platform for success. You can find all information on current training courses and offers at: www.drapalin.de/fklogin
THESE PRODUCTS ARE DISTRIBUTED IN GERMANY BY DRAPALIN
Drapalin Pharmaceuticals GmbH from Munich has been acting as one of the first German importers and wholesalers of medical cannabis since 2018. Their reliable supply of quality products and the active exchange of knowledge with physicians, pharmacists and patient associations establishes their platform for success. You can find all information on current training courses and offers at: www.drapalin.de/fklogin
Lana Korneva
“We are proud to be the first pharmaceutical wholesaler to supply medical cannabis flowers from Africa to pharmacies throughout Germany since August 2021. In doing so, we have made history together with our Lesotho partner MG Health.”